Navigation Links
MedImmune to present 4 abstracts on RSV and influenza at 47TH Annual IDSA Meeting
Date:10/30/2009

p>BACKGROUND: In September 2007, the approval of live attenuated influenza vaccine (LAIV) was expanded for use in children between 24 and 59 months in age. The vaccine was not approved for use in children younger than 24 months, or for use in children with asthma or recurrent wheezing, or those with altered immunocompetence. This study evaluates the usage and safety of the vaccine in those patient populations younger than 59 months of age that were not in the approved indication. The study found that healthcare providers appear to be complying with the indications for the use of LAIV in children <5 years, and no adverse safety outcomes were detected in the small number of children in unapproved groups who received the vaccine.

  • Whole Genome Transcriptional Analysis of the Early Immune Responses Induced by Live Attenuated and Inactivated Influenza Vaccines in Young Children Zhu W, et al. Poster Session: October 31, 2009; 12:30-2:00 PM; Hall A / Poster #1181

    BACKGROUND: This study examined the early genomic immune response to live attenuated and inactivated vaccines in previously unvaccinated children 12 to 35 months of age. Among LAIV recipients, an increase in interferon (a natural anti-viral immune protein) production was seen, which may partly explain previous clinical study observations of LAIV-induced protection against illness in the first 2 weeks after administration.

  • Influenza-Associated Antibiotic Use in Children Receiving Live Attenuated Influenza Vaccine Compared With Inactivated Influenza Vaccine Belshe R, et al. Poster Session: October 31, 2009; 12:30-2:00 PM; Hall A / Poster #1180

    BACKGROUND: Influenza illness in children commonly results in the unnecessary use of prescription antibiotics. This analysis evaluated the efficacy of live attenuated influenza vaccine (LAIV) and trivalent inactivated influenza vaccine (TIV) in preventing antibiotic use in children ranging from six months to 17 years in age. Overa
    '/>"/>


  • Contact: Tor Constantino
    301-398-5801
    Edelman Public Relations
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. MedImmune to present data on RSV and influenza at 2009 AAP National Conference and Exhibition
    2. MedImmune Receives U.S. Government Order for Additional 29 Million Doses of Nasal Spray Vaccine for 2009 H1N1 Influenza
    3. Catalyst Biosciences Announces Agreement With MedImmune to Discover and Develop Engineered Protease Therapeutics
    4. MedImmune Expands Access for Eligible Premature Infants to Receive Synagis(R) at No Cost
    5. Medarex to Receive Milestone Payment from MedImmune for Allowance of an Investigational New Drug Application for MEDI-546
    6. MedImmune grants 5 new fellowships to help expand premature infant follow-up care research
    7. MedImmune Further Expands Autoimmune Disease Research Program Through Collaboration with SBI Biotech
    8. MedImmune Prepared to Support Implementation of Expanded ACIP Recommendations for Influenza Vaccinations
    9. MedImmune Expands Scientific and Engineering Leadership
    10. Micromet and MedImmune to Present New Clinical Data for Anti-CD19 BiTE(R) Antibody at American Society of Hematology Annual Meeting Showing Objective Clinical Responses in Relapsed Non-Hodgkins Lymphoma Patients
    11. MedImmune presents new pharmaco-economic data at AAP regarding infants at high risk for RSV
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/20/2015)... Burlington, Vt. (PRWEB) April 20, 2015 ... environmental networks, is excited to announce that Kate Williams, the ... CEO, effective May 1, 2015. , Williams has been part ... nearly decade-long tenure as Executive Director of the Northern Forest ... Williams has dedicated her career to the stewardship of and ...
    (Date:4/20/2015)... Today the members of the new ... National Alliance-National Ovarian Cancer Coalition Translational Research Dream ... on “DNA Repair Therapies for Ovarian Cancer,” building ... as a common weakness in ovarian cancer. Researchers ... of ovarian cancer by developing a web-based approach ...
    (Date:4/20/2015)... Grateful Dead originally formed in ... until 1995. The group was more than just about rock ... folk, space rock, country, and other genres to put together ... band. The group was inducted into the Rock and Roll ... more than 35 million records worldwide. This year marks ...
    (Date:4/20/2015)... 2015 Northern Westchester Hospital ... Services introduced their new 5-star “Patient Experience” rating system ... Healthcare Providers and Systems) survey of hospital patient treatment ... experiences during a recent hospital stay. , ... through June 30, 2014 can be reviewed online ...
    (Date:4/20/2015)... Insuranceautoquote.info has released a new blog post ... online . , Affordable auto insurance quotes can ... should always compare online car insurance rates in their ... website: . http://insuranceautoquote.info , The process is ... in a few minutes and the search engine offers ...
    Breaking Medicine News(10 mins):Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4Health News:Grateful Dead Tickets at Levi’s Stadium in Santa Clara: Ticket Down Slashes Grateful Dead Tickets in Santa Clara @ Levi’s Stadium for "Fare Thee Well" 50th Anniversary 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3Health News:Affordable Auto Insurance Quotes Can Be Found Online, Fast and Easy 2
    ... , , , ... (Nasdaq: HTWR ) (ASX: HIN) announced today the completion ... stock in a private placement in the United States and Australia ... a purchase price of US$22.00 per share resulting in gross proceeds ...
    ... pose dangers, experts say , MONDAY, Aug. 17 (HealthDay News) ... amounts of indoor ozone, then "spit" it out in the ... lungs, new research suggests. , "They are saying that compounds ... irritation to the skin," explained one expert, Rajat Sethi, an ...
    ... two disorders , MONDAY, Aug. 17 (HealthDay News) -- Dr. ... commonly used to combat high blood pressure can help prevent ... But people in the know tend to listen carefully to ... University, because one of his ideas was crucial in the ...
    ... BEDFORD, Mass., Aug. 17 Insulet Corporation (Nasdaq: ... its OmniPod(R) Insulin Management System, today announced the appointment of ... created role, Mr. Devlin will lead the Company,s Sales and ... , "Peter brings a distinguished track record ...
    ... interaction, researchers prevent disease production , MONDAY, Aug. ... to block HIV infections in the lab with synthetic ... , In the study, researchers developed synthetic molecules that ... called gp41 to interact with proteins in host cells. ...
    ... monitored in those with head and neck malignancies, researchers ... levels of post-treatment pain in head and neck cancer ... U.S. researchers have found. , Their study included 339 ... of life at diagnosis and three, six, nine and ...
    Cached Medicine News:Health News:HeartWare International, Inc. Closes US$60 Million Financing 2Health News:HeartWare International, Inc. Closes US$60 Million Financing 3Health News:Toxins May Form When Skin, Indoor Ozone Meet 2Health News:Toxins May Form When Skin, Indoor Ozone Meet 3Health News:Blood Pressure Drug Might Work Against MS 2Health News:Blood Pressure Drug Might Work Against MS 3Health News:Insulet Appoints Peter J. Devlin as Chief Commercial Officer 2Health News:Synthetic Protein Thwarts HIV Infection in Lab 2Health News:Pain Level May Predict Survival in Certain Cancer Patients 2
    (Date:4/20/2015)... April 21, 2015  Following is the daily "Profile ... LIFESAVING MEDICINE Profile America ... medicines — insulin —became available for general use this ... people suffering from diabetes. Insulin is a hormone produced ... of carbohydrates in the human body. It was first ...
    (Date:4/20/2015)... 2015 Actavis plc (NYSE: ACT ... , Chief Communications Officer, will retire from Actavis ... conjunction with Mayr,s retirement, Alex Kelly , ... Chief Communications Officer, effective immediately. Prior to joining ... President, Chief Communications Officer, Public Affairs and Investor ...
    (Date:4/20/2015)... SEATTLE , April 20, 2015   Precision ... webinar series designed to highlight advances in cardiovascular imaging ... former president of the Society for Cardiovascular Magnetic ... that will highlight improvements in patient management by providing ... This presentation will help attendees to better understand appropriate ...
    Breaking Medicine Technology:U.S. Census Bureau Daily Feature for April 21 2Actavis Announces Retirement of Charles M. Mayr 2Actavis Announces Retirement of Charles M. Mayr 3Educational Webinar Teaches Improved Patient Management Through Broader Access to Cardiac MRI 2
    ... YORK, Nov. 9 MISSION Skincare®, the innovative skincare ... Mia Hamm, and other world class athletes, will be ... of more than 5,000 CVS/pharmacy locations across the country ... and sun care products, MISSION and CVS/pharmacy have set ...
    ... Va., Nov. 9 TessArae® LLC, a global ... of new integrated product solutions for genetic testing ... The combination of TessArae,s expertise in microarray-based ... analysis software enables screening for all targeted mutations ...
    Cached Medicine Technology:Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 2Glamour Magazine Woman of the Year and MISSION Skincare Co-Founder, Serena Williams, Teams Up with CVS/pharmacy to Launch National 'Active Lifestyle Skincare Destinations' 3TessArae Delivers Lower Cost Option to Genetic Testing Market 2
    5mm from bend to tip 0.3x2.0mm Tip, Oblong 2 Sided Straight, at 45 degrees; In Titanium...
    Angled 40 Degrees, 0.6x0.8 Elliptical Tip; in Titanium...
    Double ended with 0.5mm x 10mm and 1.0mm x 15mm blades; both blades gently curved; round serrated handle, In Titanium....
    Bend with "H" Shaped Tip, LEFT; in Titanium....
    Medicine Products: